Central Lancashire Formulary Formulary

	Central Lancashire Formulary
	Lancashire Teaching Hospitals NHS Foundation Trust Chorley and South Ribble CCG Greater Preston CCG

Search

Formulary Chapter 13: Skin - Full Chapter

13.06.01

Topical preparations for acne

13.06.01

Benzoyl peroxide and azelaic acid

Benzoyl Peroxide

Formulary

Azelaic Acid

Formulary

Skinoren ^®cream 20%

13.06.01

Topical antibacterials for acne

Benzoyl Peroxide 5% with Clindamycin 1% (Duac^® Once Daily)

Formulary

Duac ^®Once Daily

Clindamycin 1% (Dalacin T^®)

Formulary

Dalacin T ^®

Erythromycin 40mg with Zinc Acetate 12mg/mL (Zineryt^®)

Formulary

Zineryt ^®

13.06.01

Topical retinoids and related preparations for acne

Adapalene

Formulary

Differin ^®

cream / gel

Isotretinoin with erythromycin

Formulary

Isotrexin ^®Isotretinoin 0.05% and erythromycin 2% gel

Tretinoin with clindamycin

Formulary

Treclin^®tretinoin 250microgram per 1g and clindamycin 10mg per 1g gel

13.06.01

Other topical preparations for acne

Nicotinamide

Formulary

Nicam ^®nicotinamide 4% gel

....

Key

	Notes
	Section Title (top level)
	Section Title (sub level)
	First Choice item
	Non Formulary section
	Restricted Drug
	Unlicensed
	Display tracking information
	Link to adult BNF
	Link to children's BNF
	Link to SPCs
	Scottish Medicines Consortium

	Cytotoxic Drug
	Controlled Drug
	High Cost Medicine
	Cancer Drugs Fund
	NHS England
	Homecare
	CCG

Traffic Light Status Information

Status	Description
	Suitable for prescribing in primary care following recommendation or initiation by a specialist. Little or no specific monitoring required. Patient may need a regular review, but this would not exceed that required for other medicines routinely prescribed in primary care. Brief prescribing document or information sheet may be required.
	Suitable for prescribing in primary care following recommendation or initiation by a specialist. Minimal monitoring required. Patient may need a regular review, but this would not exceed that required for other medicines routinely prescribed in primary care. Full prior agreement about patient’s on-going care must be reached under the shared care agreement.
	Initiated by specialist and transferred to primary care following a successful initiation period. Significant monitoring required on an on-going basis. Full prior agreement about patient’s on-going care must be reached under the shared care agreement. Suitable for enhanced service.
	NOT recommended for use by the NHS in Lancashire. Includes medicines that NICE has not recommended for use and terminated technology appraisals, unless there is a local need.
	Products shown as blue have different Traffic Light List classifications dependent on indication. See the accompanying text next to the product for further information
	Appropriate for initiation and ongoing prescribing in both primary and secondary care. Generally, little or no routine drug monitoring is required.
	Low Priority for Prescribing - see Low Priority for Prescribing Policy
	Medicine is supplied by the hospital for the duration of the treatment course. Primary care initiation or continuation of treatment is not recommended unless exceptional circumstances such as specialist GP.
	Prescribing restricted to Specialist Centres only